Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase-1 expression in murine microglia by glioma-derived soluble factors: Laboratory investigation

Journal of Neurosurgery

Volumn 108, Issue 2, 2008, Pages 311-319

  Nakano, Yoshiteru ^a   Kuroda, Etsushi ^a   Kito, Tomohiro ^b   Uematsu, Satoshi ^c   Akira, Shizuo ^c   Yokota, Akira ^a   Nishizawa, Shigeru ^a   Yamashita, Uki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Japan Organization of Occupational Health and Safety   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Glioma; Immune response; Microglia; Microsomal prostaglandin E synthase 1; Mouse; Prostaglandin E2

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; CYCLOOXYGENASE 2; EP4 RECEPTOR; ISOMERASE; MESSENGER RNA; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E SYNTHASE; SULFONAMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CELL CULTURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GLIOMA; IMMUNE RESPONSE; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; COCULTURE; CULTURE MEDIUM; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; MICROSOME; MOUSE STRAIN;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FEMALE; GLIOMA; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICROGLIA; MICROSOMES; NITROBENZENES; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38949158428     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/2/0311     Document Type: Article

References (38)

1. 2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production. J Leukoc Biol 76: 227-236, 2004
2. Akasaki Y, Liu G, Chung NH, Ehtesham M, Black KL, Yu JS: Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J Immunol 173:4352-4359, 2004
3. Badie B, Bartley B, Schartner J: Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J Neuroimmunol 133:39-45, 2002
4. Badie B, Schartner J: Role of microglia in glioma biology. Microsc Res Tech 54:106-113, 2001
5. Badie B, Schartner JM, Hagar AR, Prabakaran S, Peebles TR, Bartley B, et al: Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. Clin Cancer Res 9:872-877, 2003
6. Cserr HF, Knopf PM: Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13:507-512, 1992
7. Couldwell WT, Dore-Duffy P, Apuzzo ML, Antel JP: Malignant glioma modulation of immune function: relative contribution of different soluble factors. J Neuroimmunol 33:89-96, 1991
8. Flick DA, Gifford GE: Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167-175, 1984
9. Graeber MB, Scheithauer BW, Kreutzberg GW: Microglia in brain tumors. Glia 40:252-259, 2002
10. Harding P, Balasubramanian L, Swegan J, Stevens A, Glass WF II: Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells. Kidney Int 69:1578-1585, 2006
11. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP: Prostaglandins as modulators of immunity. Trends Immunol 23:144-150, 2002
12. Jakobsson PJ, Thorén S, Morgentern R, Samuelsson B: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, including enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 96:7220-7225, 1999
13. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, et al: Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60:4926-4931, 2000
14. 2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol 155:4604-4612, 1995
15. Kito T, Kuroda E, Yokota A, Yamashita U: Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-γ-regulated nitric oxide. J Neurosurg 98:385-392, 2003
16. Kito T, Kuroda E, Yokota A, Yamashita U: Enhancement of macrophage cytotoxicity against murine gliomas by interferon beta: increase in nitric oxide production in response to glioma-derived soluble factors. J Neurosurg 97:619-626, 2002
17. Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318, 1996
18. 2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol 170: 757-764, 2003
19. 2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLA-2 T cells. Clin Exp Immunol 127:263-269, 2002
20. 2 levels in patients with brain tumors before and after tumor removal. J Neurooncol 57:147-150, 2002
21. 2. Mol Pharmacol 60:36-41, 2001
22. 2 production by membranebound prostaglandin E synthase-2 via both cyclooxygenase-1 and -2. J Biol Chem 278:37937-37947, 2003
23. 2 synthesis by glioma cells. J Neurosurg 104:574-582, 2006
24. Ohyama K, Kikuchi H, Oda Y, Moritake K, Yamasaki T: [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells.] No To Shinkei 45:525-530, 1993 (Jpn)
25. Okada K, Kuroda E, Yoshida Y, Yamashita U, Suzumura A, Tsuji S: Effects of interferon-beta on the cytokine production of astrocytes. J Neuroimmunol 159:48-54, 2005
26. Parney IF, Hao C, Petruk KC: Glioma immunology and immunotherapy. Neurosurgery 46:778-792, 2000
27. 2 production by murine microglia. J Immunol 172:5707-5713, 2004
28. Sawamura Y, Diserens AC, deTribolet N: In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes. J Neurooncol 9:125-130, 1990
29. Schartner JM, Hagar AR, van Handel M, Zhang L, Nadkarni N, Badie B: Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51:279-285, 2005
30. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF: Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61:4375-4381, 2001
31. Streit WJ: Microglial response to brain injury: a brief synopsis. Toxicol Pathol 28:28-30, 2000
32. Streit WJ, Walter SA, Pennell NA: Reactive microgliosis. Prog Neurobiol 57:563-581, 1999
33. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kanagawa K, Kojima M, et al: Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291:884-889, 2002
34. 2 biosynthesis. J Biol Chem 275:32775-32782, 2000
35. 2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 168: 5811-5816, 2002
36. van Rossum D, Hanisch UK: Microglia. Metab Brain Dis 19: 393-411, 2004
37. 2 in microglia. J Neurochem 88:939-947, 2004
38. Yamada M, Shimizu K, Miyao Y, Hayakawa T, Nakajima K, Nakahira K, et al: Migration of genetically labeled glioma cells after implantation into murine brain. J Neurosci Res 38:415-423, 1994